Examkin

Soru

Zorluk: OrtaPelvic Floor Disorders and Urogynecology

A 34-year-old woman comes to the urogynecology clinic complaining of chronic, severe suprapubic pelvic pain that worsens as her bladder fills and is temporarily relieved by voiding. She reports urinating up to 15 times during the day and 4 times at night. Over the past year, she has received three courses of antibiotics for suspected cystitis, but her symptoms persisted and urine cultures were consistently negative. Pelvic examination demonstrates tenderness at the bladder base but no anterior or posterior vaginal wall prolapse.

Assume a clinical diagnosis of interstitial cystitis/bladder pain syndrome (IC/BPS). Arrange the following diagnostic and management steps in the correct sequential order according to standard escalating treatment guidelines, from initial presentation to refractory disease.

  1. 1Obtain a urinalysis and urine culture to rule out active infection
  2. 2Implement dietary modifications and stress reduction techniques
  3. 3Initiate oral pharmacotherapy with agents such as amitriptyline or pentosan polysulfate
  4. 4Perform cystoscopy with therapeutic hydrodistention under anesthesia
  5. 5Administer intradetrusor botulinum toxin A injections

Cevap

The correct sequential order for managing interstitial cystitis/bladder pain syndrome (IC/BPS) is: Urinalysis and culture -> Dietary modifications -> Oral pharmacotherapy -> Cystoscopy with hydrodistention -> Intradetrusor botulinum toxin A.
The correct sequence for managing interstitial cystitis/bladder pain syndrome (IC/BPS) follows a strict escalation of invasiveness based on clinical guidelines. First, a urinalysis and culture must rule out active infection. Second, first-line management involves behavioral changes, particularly avoiding dietary triggers like caffeine, alcohol, and acidic foods. Third, second-line management introduces oral medications such as amitriptyline or pentosan polysulfate sodium. Fourth, if medical management fails, third-line therapy utilizes cystoscopy with hydrodistention under anesthesia, which can alleviate symptoms and treat Hunner lesions. Finally, fourth-line therapy incorporates intradetrusor botulinum toxin A injections for severe, refractory cases.

Adım Adım Çözüm

1
Rule out reversible and infectious causes.
Urinalysis and urine culture.
Urinary tract infections are the most common cause of urinary frequency and suprapubic pain, and must be excluded before diagnosing a chronic pain syndrome.
2
Apply non-invasive, first-line conservative treatments.
Dietary modifications and stress reduction.
Behavioral therapy is the least invasive approach, carries no risk of adverse medication effects, and provides significant relief for many patients.
3
Escalate to systemic medical therapy.
Oral pharmacotherapy with amitriptyline or pentosan polysulfate.
Second-line treatment is indicated when lifestyle changes fail to adequately control symptoms.
4
Proceed to minimally invasive procedural interventions.
Cystoscopy with hydrodistention.
Third-line therapy physically stretches the bladder capacity and allows for the evaluation and fulguration of Hunner lesions, but requires anesthesia.
5
Utilize advanced interventions for highly refractory disease.
Intradetrusor botulinum toxin A injections.
Used as a fourth-line option because it carries a risk of urinary retention requiring intermittent self-catheterization.

Anahtar Kavram

Interstitial cystitis/bladder pain syndrome (IC/BPS) is managed using a step-wise escalation algorithm, progressing from non-invasive behavioral and dietary modifications to oral medications, and reserving invasive procedures (hydrodistention, botulinum toxin) for refractory cases.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Pelvic Floor Disorders and Urogynecology

Bu konudan daha fazla soru